Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

100%(5 trials)

Phase Distribution

Ph phase_2

40%

Ph phase_1

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

3(60.0%)

Phase 2Efficacy & side effects

2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (60.0%)

Phase 22 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_1

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

NCT01237899

Clinical Trials (5)

Showing 5 of 5 trials

NCT02300259Phase 1

A Study of LY2623091 in Healthy Participants

Completed

NCT02194465Phase 2

A Study of LY2623091 in Participants With High Blood Pressure

Completed

NCT02242981Phase 1

A Study of How the Body Breaks Down and Eliminates LY2623091

Completed

NCT01427972Phase 2

A Study of LY2623091 in Male and Females With Chronic Kidney Disease

Completed

NCT01237899Phase 1

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5